GnRH agonist for gonadal protection during chemotherapy

Affiliations

¹ Cleveland Clinic Lerner College of Medicine and Obstetrics, Gynecology and Women's Health Institute Cleveland, Cleveland, OH, USA falcont@ccf.org.
² Solid Tumor Oncology, Cleveland Clinic Tausig Cancer Institute, Cleveland, OH, USA.

Comment

Tommaso Falcone et al. Hum Reprod. 2015 Dec.

. 2015 Dec;30(12):2711-2.

doi: 10.1093/humrep/dev258. Epub 2015 Oct 13.

¹ Cleveland Clinic Lerner College of Medicine and Obstetrics, Gynecology and Women's Health Institute Cleveland, Cleveland, OH, USA falcont@ccf.org.
² Solid Tumor Oncology, Cleveland Clinic Tausig Cancer Institute, Cleveland, OH, USA.

No abstract available

Comment on

GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro.
Bildik G, Akin N, Senbabaoglu F, Sahin GN, Karahuseyinoglu S, Ince U, Taskiran C, Selek U, Yakin K, Guzel Y, Ayhan C, Alper E, Cetiner M, Balaban B, Mandel NM, Esen T, Iwase A, Urman B, Oktem O. Bildik G, et al. Hum Reprod. 2015 Dec;30(12):2912-25. doi: 10.1093/humrep/dev257. Epub 2015 Oct 13. Hum Reprod. 2015. PMID: 26466909